CR

CreoSG Co.,Ltd.

Offers IT solutions to financial institutions and develops vaccines for HIV and coronaviruses.

040350 | KO

Overview

Corporate Details

ISIN(s):
KR7040350001
LEI:
Country:
South Korea
Address:
서울특별시 강남구 테헤란로13길 31-1 4층(역삼동, 일리빌딩), 강남구
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

CreoSG Co., Ltd. operates as a diversified company with two primary business segments: IT solutions and biotechnology. The IT division specializes in developing and supplying software and next-generation systems for financial institutions, offering services that include application development, IT outsourcing, and infrastructure management. Concurrently, the company has a significant focus on the biotechnology sector, primarily conducting vaccine research and development. This division leverages a proprietary recombinant VSV (Vesicular Stomatitis Virus) vector platform technology to develop novel vaccines, with key projects targeting HIV/AIDS and various coronaviruses.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-19 00:00
Share Issue/Capital Change
증권발행결과(자율공시) (제3자배정-소액공모)
Korean 7.5 KB
2025-09-19 00:00
Share Issue/Capital Change
소액공모실적보고서
Korean 29.0 KB
2025-09-18 00:00
Major Shareholding Notification
최대주주변경을수반하는주식담보제공계약해제ㆍ취소등
Korean 19.8 KB
2025-09-11 00:00
Share Issue/Capital Change
[기재정정]주요사항보고서(유상증자결정)
Korean 51.0 KB
2025-09-11 00:00
Share Issue/Capital Change
소액공모공시서류(지분증권)
Korean 2.2 MB
2025-09-10 00:00
Share Issue/Capital Change
[기재정정]주요사항보고서(유상증자결정)
Korean 60.5 KB
2025-09-08 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 163.4 KB
2025-09-03 00:00
Share Issue/Capital Change
주요사항보고서(유상증자결정)
Korean 39.7 KB
2025-09-01 00:00
Capital/Financing Update
전환사채(해외전환사채포함)발행후만기전사채취득 (제22회차)
Korean 9.3 KB
2025-08-29 00:00
Share Issue/Capital Change
[기재정정]주요사항보고서(유상증자결정)
Korean 44.9 KB
2025-08-20 00:00
Regulatory News Service
불성실공시법인지정 (공시불이행)
Korean 6.1 KB
2025-08-14 00:00
Audit Report / Information
반기검토(감사)의견부적정등사실확인(자본잠식률100분의50이상또는자기자본10억원미만포함)
Korean 12.2 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.9 MB
2025-07-30 00:00
Share Issue/Capital Change
[기재정정]주요사항보고서(유상증자결정)
Korean 44.6 KB
2025-07-29 00:00
Regulatory News Service
불성실공시법인지정예고 (공시불이행)
Korean 5.0 KB

Automate Your Workflow. Get a real-time feed of all CreoSG Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CreoSG Co.,Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for CreoSG Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Incross Co.,Ltd. Logo
A digital marketing firm offering data-driven ad solutions via proprietary AI and video platforms.
South Korea
216050
INEST,Inc. Logo
Offers ASP solutions and HR support to businesses and sells mobile devices to consumers.
Japan
7111
Innate Pharma Logo
Clinical-stage biotech developing NK cell-engaging antibodies for cancer immunotherapy.
France
IPH
Innovation Inc. Logo
Drives B2B growth via digital media, IT solutions, M&A advisory, and venture capital.
Japan
3970
Innventure, Inc. Logo
Founds, funds, and scales companies using breakthrough R&D from multinational corporations.
United States of America
INV
Inotiv, Inc. Logo
CRO providing nonclinical drug discovery, research models, and analytical services for life sciences.
United States of America
NOTV
INTAGE HOLDINGS Inc. Logo
Marketing research & business intelligence for consumer goods, healthcare & enterprise tech.
Japan
4326
IntegraGen Logo
Genomic analysis & molecular diagnostics for cancer and rare diseases for researchers and labs.
France
ALINT
INTENSITY THERAPEUTICS, INC. Logo
Develops injected therapies to kill tumors locally and activate a systemic immune response.
United States of America
INTS
InterDigital, Inc. Logo
Develops and licenses essential wireless, video, and AI technologies for mobile devices and networks.
United States of America
IDCC

Talk to a Data Expert

Have a question? We'll get back to you promptly.